期刊文献+

延迟增强MRI对心房颤动患者左心房心肌纤维化的评估价值 被引量:9

The assessment of the left atrial myocardial fibrosis of atrial fibrillation with late Gadolinium enhancement MRI
原文传递
导出
摘要 目的 探讨2D延迟增强MRI(LGE-MRI)技术对心房颤动(简称房颤)患者左心房心肌纤维化评估的临床应用价值。方法 回顾性分析我院自2015年3月至2016年12月拟行射频消融术的房颤患者49例,所有患者术前均行LGE-MRI检查。由2名富有经验的影像诊断医师对MR图像分析评估,轴位像上将左心房划分为8个象限,根据延迟强化程度及范围,将左心房纤维化分为4级。全部患者三维电解剖标测(CARTO),左心房电解剖图像均在房颤导管消融术前复律后窦性心律下左房基质标测取得,并根据其低电压分布分级。采用Kappa检验来评估MRI延迟增强左心房心肌纤维化和CARTO系统左心房心内膜电压重建图像分级的一致性。结果 49例心房颤动患者LGE-MRI及CARTO左心房电解剖图像均成功完成。LGE-MRI左心房纤维化分级0级17例,Ⅰ级10例,Ⅱ级11例,Ⅲ级11例;CARTO心房纤维化分级0级17例,Ⅰ级9例,Ⅱ级12例,Ⅲ级11例。LGE-MRI心房纤维化诊断准确率为81.6%(40/49),与CARTO分级间一致性检验好(Kappa=0.751,P〈0.01)。结论 LGE-MRI技术能够较准确评估房颤患者左心房心肌纤维化程度,有助于临床对合适的患者行导管消融术。 Objective To investigate the clinical value of 2 dimension late Gadolinium enhancement MRI (LGE-MRI) technique for the evaluation of atrial myocardial fibrosis in patients with atrial fibrillation.Methods Forty-nine cases of atrial fibrillation in our hospital from March 2015 to December 2016 were retrospectively collected. The LGE-MR was acquired by the Siemens 3.0 T MR machine before the catheter ablation. The findings of LGE-MR were evaluated by two experienced doctors. The left atrium (LA) were manually segmented into 8 regions in axial view. All patients were classified into 4 stages based on the extent of enhancement, stage 0: absence of enhancement, stage Ⅰ: enhancement appeared in minimal two consecutive slices in single region, stage Ⅱ: enhancement in two regions, stage Ⅲ: enhancement in three or more regions. All electroanatomic maps were obtained after electrical conversion during catheter ablation. The Kappa test was used to assess the consistency of LGE-MRI left atrial myocardial fibrosis and CARTO system of the left atrial endocardial voltage reconstruction.Results Forty-nine cases of atrial fibrillation with LGE-MRI and CARTO were included. There were 17 cases of atrial fibrosis stage 0, 10 cases of stage Ⅰ, 11 cases of stage Ⅱ, 11 cases of stage Ⅲ according to LGE-MRI findings;There were 17 cases of atrial fibrosis stage 0, 19 cases of stage Ⅰ, 12 cases of stage Ⅱ, 11 cases of stage Ⅲ with reference to CARTO findings. The diagnostic accuracy of the LGE-MRI atrial fibrosis was 81.6% (40/49), of which the correlation was good (Kappa= 0.751, P〈0.001).Conclusions LGE-MRI can accurately assess the degree of left atrial myocardial fibrosis in patients with atrial fibrillation, help to select the proper candidate and strategy in catheter ablation.
出处 《中华放射学杂志》 CAS CSCD 北大核心 2018年第3期172-176,共5页 Chinese Journal of Radiology
基金 徐州市科技计划项目(KCl4SX012)
关键词 心房颤动 磁共振成像 对比研究 Atrial fibrillation Magnetic resonance imaging Comparative study Atrial fibrillation Magnetic resonance imaging Comparative study
  • 相关文献

参考文献2

二级参考文献35

  • 1Elliott P,McKenna WJ. Hypertrophic cardiomyopathy. Lancet,2004,363:1881-1891.
  • 2Salerno M, Kramer CM. Prognosis in hypertrophic cardiomyopathywith contrast-enhanced cardiac magnetic resonance : the futurelooks bright. J Am Coll Cardiol,2010,56: 888-889.
  • 3Cerqueira MD, Weissman NJ,Dilsizian V,et al. Standardizedmyocardial segmentation and nomenclature for tomographic imagingof the heart : a statement for healthcare professionals from theCardiac Imaging Committee of the Council on Clinical Cardiologyof the American Heart Association. Circulation, 2002, 105 :539-542.
  • 4Gersh BJ’Maron BJ,Bonow RO et al. 2011 ACCF/AHA Guidelinefor the Diagnosis and Treatment of Hypertrophic Cardiomyopathy :a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines :developed in collaboration with the American Association forThoracic Surgery, American Society of Echocardiography, AmericanSociety of Nuclear Cardiology,Heart Failure Society of America,Heart Rhythm Society, Society for Cardiovascular Angiography andInterventions,and Society of Thoracic Surgeons. J Am CollCardiol,2011,58: e212-e260.
  • 5Moon JC,McKenna WJ,McCrohon JA,et al. Toward clinical riskassessment in hypertrophic cardiomyopathy with gadoliniumcardiovascular magnetic resonance. J Am Coll Cardiol, 2003 ,41 :1561-1567.
  • 6Maron MS, Maron BJ, Harrigan C, et al. Hypertrophiccardiomyopathy phenotype revisited after 50 years withcardiovascular magnetic resonance. J Am Coll Cardiol,2009,54 ??220-228.
  • 70'Hanlon R,Grasso A, Roughton M, et al. Prognostic significanceof myocardial fibrosis in hypertrophic cardiomyopathy. J Am CollCardiol,2010,56: 867-874.
  • 8Maron BJ,Olivotto I,Spirito P,et al. Epidemiology of hypertrophiccardiomyopathy-related death : revisited in a large non-referral-based patient population. Circulation,2000,102 : 858-864.
  • 9Papavassiliu T,Germans T, Fliichter S, et al. CMR finding inpatients with hypertrophic cardiomyopathy and atrial fibrillation. JCardiovasc Magn Reson ,2009 ,11 : 34-42.
  • 10Gruver EJ, Fatkin D, Dodds GA, et al. Familial hypertrophiccardiomyopathy and atrial fibrillation caused by Arg663 His beta-cardiac myosin heavy chain mutation. Am J Cardiol, 1999,83(12A) : 13H-18H.

共引文献14

同被引文献70

引证文献9

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部